Karin Kolmodin

Q: a molecular dynamics program for free energy calculations and empirical valence bond simulations in biomolecular systems

John Marelius, Karin Kolmodin, Isabella Feierberg et al. · Journal of Molecular Graphics and Modelling · 1998 · 327 citations

Natural Sciences, Chemistry, Physics +14

Application of Fragment-Based Lead Generation to the Discovery of Novel, Cyclic Amidine β-Secretase Inhibitors with Nanomolar Potency, Cellular Activity, and High Ligand Efficiency

Philip D. Edwards, Jeffrey S. Albert, Mark Sylvester et al. · Journal of Medicinal Chemistry · 2007 · 211 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

State-of-the-art Tools for Computational Site of Metabolism Predictions: Comparative Analysis, Mechanistical Insights, and Future Applications

Lovisa Afzelius, Catrin Hasselgren Arnby, Anders Broo et al. · Drug Metabolism Reviews · 2007 · 140 citations

Medicine, Biochemistry, Pharmacology +17

Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease

Fredrik Jeppsson, Susanna Eketjäll, Juliette Janson et al. · Journal of Biological Chemistry · 2012 · 138 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides

Britt‐Marie Swahn, Karin Kolmodin, Sofia Karlström et al. · Journal of Medicinal Chemistry · 2012 · 100 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17